Recruiting

Observational Study

Sponsor:

West Virginia University

Code:

NCT06808503

Conditions

Suicide Prevention

Suicide

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Accepted

Interventions

NIMH Clinical Pathway

Study Details

Brief summary:

This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate.

Investigators aim to do the following:

1. Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs).
2. Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.

Conditions

Suicide Prevention

Suicide

Study ID

NCT06808503

Start date

Oct 2, 2024

Status verified date

Apr, 2026

Completion date

May, 2027

Anticipated

Primary completion date

May, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Youth who are receiving services at the school-based health centers to participate
  • Parents must be able to give legal consent for themselves and their children to participate
  • Youth and Parent must be English-speaking
  • Youth must also be able to give signed assent to participate
  • Youth must be cognitively and medically able to participate in study activities

Exclusion Criteria:

  • Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.

Study Design

Enrollment

30 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Screening

Interventions and Outcome Measures

Arms

no intervention: Treatment As Usual (TAU)

Review all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present.

active comparator: NIMH Clinical Pathway

Implementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up.

Interventions

NIMH Clinical Pathway

Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.

Primary outcome measure

  • Number of Patients Screened for Suicidal Risks-Site 1 [ Time Frame: Total period of 3 Months ]
  • Number of Patients Screened for Suicidal Risks-Site 2 [ Time Frame: Total period of 6 Months ]
  • Number of Patients Reporting Suicidal Risks-Site 1 [ Time Frame: Total period of 12 Months ]
  • Number of Patients Reporting Suicidal Risks-Site 2 [ Time Frame: Total period of 12 Months ]

Central Contacts and Locations

Central contacts

Mary Christensen, PhD, LICSW

304-293-3501mary.christensen@mail.wvu.edu

Locations

West Virginia University

Recruiting

Morgantown, West Virginia, United States, 26505

Contacts

Mary Christensen, PhD, LICSW

304-293-3501mary.christensen@mail.wvu.edu

Principal Investigator:

Mary Christensen, PhD, LICSW

More Information

Sponsor

West Virginia University

Last update posted

Apr 21, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by West Virginia University on 2026-04-21.